Bradley Foster & Sargent’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $42.2M | Buy |
35,186
+8,118
| +30% | +$8.29M | 0.6% | 47 |
|
|
2026
Q1 | $24.9M | Buy |
27,068
+877
| +3% | +$889K | 0.39% | 59 |
|
|
2025
Q4 | $28.1M | Buy |
26,191
+468
| +2% | +$447K | 0.41% | 55 |
|
|
2025
Q3 | $19.6M | Buy |
25,723
+652
| +3% | +$485K | 0.29% | 79 |
|
|
2025
Q2 | $19.5M | Buy |
25,071
+722
| +3% | +$561K | 0.31% | 77 |
|
|
2025
Q1 | $20.1M | Buy |
24,349
+4,656
| +24% | +$3.87M | 0.34% | 73 |
|
|
2024
Q4 | $15.2M | Sell |
19,693
-930
| -5% | -$770K | 0.26% | 86 |
|
|
2024
Q3 | $18.3M | Buy |
20,623
+442
| +2% | +$397K | 0.31% | 76 |
|
|
2024
Q2 | $18.3M | Buy |
20,181
+558
| +3% | +$446K | 0.33% | 68 |
|
|
2024
Q1 | $15.3M | Buy |
19,623
+723
| +4% | +$515K | 0.28% | 80 |
|
|
2023
Q4 | $11M | Sell |
18,900
-2,418
| -11% | -$1.41M | 0.21% | 96 |
|
|
2023
Q3 | $10M | Hold |
21,318
| – | – | 0.21% | 88 |
|
|
2023
Q2 | $10M | Buy |
21,318
+373
| +2% | +$156K | 0.21% | 88 |
|
|
2023
Q1 | $7.19M | Sell |
20,945
-55
| -0.3% | -$18.5K | 0.17% | 100 |
|
|
2022
Q4 | $7.68M | Buy |
21,000
+156
| +0.7% | +$55.3K | 0.19% | 88 |
|
|
2022
Q3 | $6.74M | Buy |
20,844
+14
| +0.1% | +$4.44K | 0.19% | 89 |
|
|
2022
Q2 | $6.75M | Buy |
20,830
+463
| +2% | +$139K | 0.17% | 96 |
|
|
2022
Q1 | $5.83M | Buy |
20,367
+3,801
| +23% | +$978K | 0.12% | 126 |
|
|
2021
Q4 | $4.58M | Buy |
16,566
+625
| +4% | +$158K | 0.09% | 137 |
|
|
2021
Q3 | $3.68M | Sell |
15,941
-4,348
| -21% | -$1.07M | 0.09% | 139 |
|
|
2021
Q2 | $4.66M | Sell |
20,289
-450
| -2% | -$90.4K | 0.11% | 124 |
|
|
2021
Q1 | $3.88M | Sell |
20,739
-12,100
| -37% | -$2.37M | 0.1% | 135 |
|
|
2020
Q4 | $5.54M | Sell |
32,839
-50
| -0.2% | -$7.46K | 0.15% | 109 |
|
|
2020
Q3 | $4.87M | Buy |
+32,889
| New | +$5.09M | 0.14% | 108 |
|
|
2020
Q1 | $4.66M | Buy |
33,579
+734
| +2% | +$101K | 0.19% | 98 |
|
|
2019
Q4 | $4.32M | Buy |
32,845
+111
| +0.3% | +$12.9K | 0.13% | 123 |
|
|
2019
Q3 | $3.66M | Sell |
32,734
-165
| -0.5% | -$18.4K | 0.12% | 128 |
|
|
2019
Q2 | $3.65M | Sell |
32,899
-231
| -0.7% | -$27.2K | 0.12% | 124 |
|
|
2019
Q1 | $4.3M | Buy |
33,130
+172
| +0.5% | +$20.9K | 0.15% | 119 |
|
|
2018
Q4 | $3.81M | Sell |
32,958
-3,570
| -10% | -$399K | 0.15% | 115 |
|
|
2018
Q3 | $3.92M | Hold |
36,528
| – | – | 0.13% | 129 |
|
|
2018
Q2 | $3.12M | Sell |
36,528
-100
| -0.3% | -$8.21K | 0.11% | 144 |
|
|
2018
Q1 | $2.83M | Buy |
36,628
+1,123
| +3% | +$90.4K | 0.11% | 144 |
|
|
2017
Q4 | $3M | Sell |
35,505
-53
| -0.1% | -$4.51K | 0.11% | 139 |
|
|
2017
Q3 | $3.04M | Sell |
35,558
-265
| -0.7% | -$21.7K | 0.12% | 136 |
|
|
2017
Q2 | $2.95M | Buy |
35,823
+404
| +1% | +$33K | 0.12% | 130 |
|
|
2017
Q1 | $2.98M | Sell |
35,419
-1,029
| -3% | -$82.4K | 0.12% | 126 |
|
|
2016
Q4 | $2.68M | Buy |
36,448
+1,455
| +4% | +$108K | 0.11% | 133 |
|
|
2016
Q3 | $2.81M | Sell |
34,993
-100
| -0.3% | -$8K | 0.12% | 122 |
|
|
2016
Q2 | $2.76M | Hold |
35,093
| – | – | 0.12% | 120 |
|
|
2016
Q1 | $2.53M | Sell |
35,093
-883
| -2% | -$66.8K | 0.12% | 121 |
|
|
2015
Q4 | $3.03M | Sell |
35,976
-250
| -0.7% | -$20.7K | 0.14% | 124 |
|
|
2015
Q3 | $3.03M | Sell |
36,226
-1,225
| -3% | -$103K | 0.15% | 121 |
|
|
2015
Q2 | $3.13M | Sell |
37,451
-1,703
| -4% | -$130K | 0.14% | 126 |
|
|
2015
Q1 | $2.85M | Sell |
39,154
-172
| -0.4% | -$12.2K | 0.13% | 130 |
|
|
2014
Q4 | $2.71M | Buy |
39,326
+225
| +0.6% | +$15.2K | 0.13% | 131 |
|
|
2014
Q3 | $2.54M | Buy |
39,101
+9,900
| +34% | +$627K | 0.12% | 139 |
|
|
2014
Q2 | $1.81M | Sell |
29,201
-3,645
| -11% | -$217K | 0.09% | 153 |
|
|
2014
Q1 | $1.93M | Hold |
32,846
| – | – | 0.1% | 141 |
|
|
2013
Q4 | $1.68M | Sell |
32,846
-208
| -0.6% | -$10.4K | 0.09% | 151 |
|
|
2013
Q3 | $1.66M | Sell |
33,054
-134
| -0.4% | -$7.01K | 0.1% | 142 |
|
|
2013
Q2 | $1.63M | Buy |
+33,188
| New | +$1.81M | 0.1% | 134 |
|
Other funds holding LLY
Bradley Foster & Sargent's LLY Position: Q2 2026 in Review
Bradley Foster & Sargent increased its Eli Lilly (LLY) stake by 30% in Q2 2026, buying an estimated $8.29M and bringing the position to 35,186 shares worth $42.2M. The position accounts for 0.6% of the portfolio, ranked #47.
Bradley Foster & Sargent first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. 4,599 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Bradley Foster & Sargent held 35,186 shares of Eli Lilly worth $42.2M as of Q2 2026.
- Bradley Foster & Sargent bought 8,118 Eli Lilly shares in Q2 2026, an estimated $8.29M.
- Eli Lilly made up 0.6% of Bradley Foster & Sargent's portfolio in Q2 2026, its #47 holding.
- Bradley Foster & Sargent first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
- 4,599 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Bradley Foster & Sargent's 13F filing for Q2 2026, filed 14 Aug 2026.